ARS Pharmaceuticals, Inc. (SPRY) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $84.28M | -5.5% |
| 2024 | $89.15M | +297063.3% |
| 2023 | $30.0K | -97.7% |
| 2022 | $1.32M | -76.1% |
| 2021 | $5.51M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $84.28M | -5.5% |
| 2024 | $89.15M | +297063.3% |
| 2023 | $30.0K | -97.7% |
| 2022 | $1.32M | -76.1% |
| 2021 | $5.51M | — |